SCCM Resource Library-Clinical Unmet Need for HDTs

Video Transcription

Video Summary

The speaker discusses clinical unmet needs and host-directed therapeutics, emphasizing the complexity and unpredictability of treatments for future pandemics. They highlight COVID-19's progression, where early treatment targets virus replication, and later stages require addressing immune responses. Despite previous successes with COVID treatments like dexamethasone and tocilizumab, they caution against assuming their efficacy in future pandemics without new studies and understanding of mechanisms, as the host response can vary. They stress the importance of learning from past experiences to expedite therapeutic development and enhance response to future pandemics.

Asset Caption

90-Minute Session | Clinical Evidence for Host-Directed Therapeutics

Meta Tag

Content Type Presentation

Membership Level Professional

Membership Level Select

Year 2024

Keywords

host-directed therapeutics

pandemic treatment

COVID-19

immune response

therapeutic development

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.